The Ritedose Corporation, Columbia, SC

Is The Ritedose Corporation registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does The Ritedose Corporation hold a South Carolina pharmacy license?

State board of pharmacy records for South Carolina are not checked: the Department of Labor, Licensing and Regulation’s board website did not respond to this index’s requests on November 6, 2026, or when tried again on November 7, 2026. The Delaware Division of Professional Regulation also lists nonresident license AD-0010076 for The Ritedose Corporation, COLUMBIA, SC, status Closed and license AD-0010081 for The Ritedose Corporation, COLUMBIA, SC, status Closed, as of Nov 10, 2026.

Has The Ritedose Corporation had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 FMD-145 letter (Sep 23, 2022) for The Ritedose Corporation. State board of pharmacy records for South Carolina are not checked: the Department of Labor, Licensing and Regulation’s board website did not respond to this index’s requests on November 6, 2026, or when tried again on November 7, 2026.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
The Ritedose Corporation
Location
Columbia, SC
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
1
Warning letters on FDA’s actions page
0
Latest action on that page
Sep 23, 2022
FDA Data Dashboard inspections
12 inspections: 5 VAI, 7 NAI; 1 published Form 483
Form 483 text on this page
1 Form 483, 1 observation
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as The Ritedose Corporation, a 503A facility, with 2 dated actions.

Document
Sep 23, 2022FMD-145 letterFMD-145 Letter Issued 09/23/2022Not linked by FDA
Mar 18, 2022Form 483483 Issued 03/18/2022FDA copy (archived)

A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists The Ritedose Corporation, Columbia, SC (FEI number 3001237796), matched to this page by exact name, city and state. It lists 12 inspections: 5 VAI, 7 NAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
Feb 28, 2025Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs)30012377961250871
Mar 22, 2022Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs)30012377961165123
Apr 18, 2019No Action Indicated (NAI)Bioresearch Monitoring (Drugs)30012377961089541
Mar 3, 2017Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs): Voluntary Action Indicated (VAI); Compliance: Devices (Devices): Voluntary Action Indicated (VAI)30012377961015894
Jul 31, 2015Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs)3001237796940802
Apr 17, 2014No Action Indicated (NAI)Drug Quality Assurance (Drugs)3001237796879447
Nov 8, 2012No Action Indicated (NAI)Drug Quality Assurance (Drugs)3001237796835663
Sep 9, 2011No Action Indicated (NAI)Drug Quality Assurance (Drugs): No Action Indicated (NAI); Compliance: Devices (Devices): No Action Indicated (NAI)3001237796744752
Jan 6, 2011Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs)3001237796712127
Sep 30, 2010No Action Indicated (NAI)Bioresearch Monitoring (Drugs)3001237796685775
Aug 12, 2010No Action Indicated (NAI)Drug Quality Assurance (Drugs): No Action Indicated (NAI); Compliance: Devices (Devices): No Action Indicated (NAI)3001237796676236
Sep 18, 2009No Action Indicated (NAI)Drug Quality Assurance (Drugs): No Action Indicated (NAI); Compliance: Devices (Devices): No Action Indicated (NAI)3001237796618185

Form 483s FDA has published for this site

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 1 numbered observation in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Mar 7, 2022 to Mar 18, 2022: 1 observation

Firm on the cover
The Ritedose Corporation, 1 Technology Cir, Manufacturer
FEI number
3001237796
FDA district office on the cover
60 Eighth Street NE Atlanta, GA 30309
Matched to this page by
FEI number on the cover; linked from actions page, Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

Observation 1

There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.

Specifically, your firm detected mold species inside ISO 5 classified areas <Redacted B4> separate monitoring events between Januaiy 28, 2021 and November 05, 2021; six (6) of which recovered Aspergillus brasiliensis. Your firm did not thoroughly investigate these mold detection events and did not perform adequate actions to connect the issues and prevent recurrence.

State board of pharmacy records

State board of pharmacy records for South Carolina are not checked: the Department of Labor, Licensing and Regulation’s board website did not respond to this index’s requests on November 6, 2026, or when tried again on November 7, 2026.

Nonresident licenses in other states

These boards list a nonresident license whose record names this pharmacy’s own name, city and state.

Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).

LicenseType as the board gives itName on the board recordLocationStatus
AD-0010076Outsourcing Facility-DistributorThe Ritedose CorporationCOLUMBIA, SCClosed
AD-0010081Outsourcing Facility-DistributorThe Ritedose CorporationCOLUMBIA, SCClosed

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.